A group of 765 females attending a Planned Parenthood Clinic was screened for gonorrhea by inoculating Thayer-Martin plates and Transgrow bottles with specimens from the cervix. Blood was obtained at the same time and tested for anti-gonococcal antibody by using the Gonosticon Dri Dot test. In this low-incidence group, 18 positive cultures were detected by culture on Thayer-Martin plates, whereas Transgrow detected only 15 positive cultures. Of the 18 patients with gonorrhea, 11-exhibited reactive serum (agglutination of the latex particles). In the total population, 64% of the patients had nonreactive serum (no agglutination) and negative cultures; 25% had reactive serum and negative cultures. When this latter group was subdivided on the basis of race, blacks and Latin Americans were found to have a higher incidence of reactive serum with a corresponding negative culture than was found in whites. Patients who were originally culture positive and nonreactive in the Gonosticon Test were retested; three out of four patients retested within 6 to 11 days after the initial screening had converted to a positive Gonosticon test.
Gonorrhea is epidemic and constitutes one of the major health problems throughout the world. In 1971 there were an estimated 2.5 million cases in the United States, with a 15% increase expected in 1972 (4) . At this rate of increase, there should have been over 3 million cases of gonorrhea in the United States in 1973, although only 823,380 cases were reported to the Center for Disease Control (5) . The task of screening and treatment of patients is complicated by the fact that approximately 90% of the females who are infected with Neisseria gonorrhoeae remain asymptomatic and thus will not be prompted to seek medical attention (6) .
Diagnosis of gonorrhea was aided greatly by the development of the selective Thayer-Martin medium (8, 9) . However, screening of large populations by culture necessitates a pelvic examination in females and urethral swab in males. Also, screening by culture methods alone has not reduced the incidence or rate of increase of gonorrhea.
Many authorities have emphasized the need for a rapid serological test to simplify and speed the screening process. Recently, a new serological test, the Gonosticon Dri Dot (Organon Inc., West Orange, N.J.), was developed to aid in screening large population groups. Our investigation has evaluated the specificity and sensitivity of this test in a group of females in whom the incidence of positive cultures for N. gonorrhoeae was relatively low.
MATERIAL AND METHODS
Media. Modified Thayer-Martin medium contained GC medium base (BBL), 1% hemoglobin (Difco), 1% defined supplement (Iso-VitaleX; BBL), vanocomycin (3.0 jg/ml), colistin (7.5 jsg/ml), nystatin (12.5 U/ml), and trimethoprim (5.0 ig/ml). Six subjects yielded a positive culture with a nonreactive Gonosticon test. All of these females were retested to determine whether antibodies would appear in the serum at a later date (Table 2) . Of the four patients retested within 11 days of the initial screening, three had converted to reactive serum. Five had converted to reactive serum within 1 month, and three of the five exhibited a strongly positive test. One patient had failed to convert when she was retested 2 months after the initial screening.
During this study we noted that the females who had a reactive Gonosticon test with a corresponding negative culture were predominantly nonwhite Americans. When all patients were grouped by race to determine the percentage of each racial group exhibiting a reactive Gonosticon test with a negative culture (Table  3) , over 41% of the black and 33% of the Latin American females were Gonosticon reactive and culture negative. Only 14.2% of the white females were in this category. The difference between white and black groups was significant at a value of P < 0.001 by use of a chi-square test (Yates correction). No significant differences were demonstrable between blacks and Latin Americans or between whites and Latin Americans. Also, no significant differences in reactivity to the Gonosticon test were evident when patients were grouped on the basis of age or method of birth control.
The percentage of each racial group yielding a positive culture regardless of the Gonosticon result was also determined (Table 3) . In this case, no significant differences were seen between the number of positive cultures from these racial groups. Table 4 lists the gradations of the Gonosticon reactions of all 765 females. A reactive Gonosticon test was present in 61% of the females with a c Of the white group, six were Gonosticon reactive and one reaction was borderline. Five of the black group were reactive, and two were negative. dThis group included four Orientals, two Asian Indians, one American Indian, and one Israeli.
eTwo of the 765 patients designated no racial group. Both had a reactive Gonosticon test and a negative culture. positive culture, whereas only 24% of the females with negative cultures were reactive. Of the females from whom N. gonorrhoeae was isolated, 33% were nonreactive by the Gonosticon test whereas 65% with negative cultures were nonreactive. The group with positive cultures had a higher percentage in each of the grades of reactivity, 1 + through 4+. This difference between culture-positive and culture-negative groups was found to be significant at P < 0.001.
Unfortunately, complete medical records for these females were unavailable. In only six of the 180 patients who exhibited a reactive Gonosticon test with a negative culture could a history of gonococcal infection be obtained (Table 5 ). Prior records indicated isolation of N. gonorrhoeae from four patients 6 months to 1 year before they were tested in this study. The remaining two patients had gonorrhea approximately 2 months before inclusion in this study. Five of these patients exhibited a 2+ Gonosticon reaction at the time of screening, and one exhibited at 3+ reaction.
DISCUSSION
Our data indicated that the Gonosticon Dri Dot test detected 61% of the cases of gonorrhea that were detectable by a single culture from the cervix. Five of the six females who had a nonreactive Gonosticon test at the time of positive culture converted to a reactive Gonosticon test within 1 month. We presumed that these patients were initially nonreactive because the disease was in too early a stage to promote antibody formation against the gonococci. The reason for lack of conversion in one patient is unknown.
Of the total population studied, 24% exhibited a reactive Gonosticon test with a corresponding negative culture. Several possibilities exist for such a combination of results. The first is that a certain percentage of these females had gonorrhea that was not detected by culture. Several studies indicate that between 13 and 34% of gonorrheal infections may be missed when a single culture is taken from the cervix (1, 2, 7) . Repeated cultures from the cervix, as well as cultures from other sites such as the rectum and pharynx, provide a more thorough screening procedure. Unfortunately, such a protocol was not possible in this investigation. The second possibility is that some of these females had antibodies to N. gonorrhoeae due to a prior infection. The data obtained from the few patients with a known past history implied that such antibodies might persist in the peripheral blood for a long time. A third possibility is that some of these patients had antibodies against N. meningitidis that cross-reacted with the N. gonorrhoeae antigen used in the Gonosticon Dri Dot test. Finally, a certain percentage of these (10) 90 (12) 39 (5) 30 (4) 21 (3) a Reactivity was graded on the basis of the size of the agglutinated latex particles. No visible agglutination was seen in nonreactive sera, whereas a serum with a 4+ reaction showed abundant agglutination. Numbers in parentheses indicate percentages. 
